ICU mortality similar for patients with hematologic CA ± chemo

May 26, 2018

(HealthDay)—Short-term mortality is similar among patients with hematologic cancer who receive chemotherapy while in the intensive care unit (ICU) versus those who do not, according to a study published online May 4 in Cancer.

Stephen M. Pastores, M.D., from the Memorial Sloan-Kettering Cancer Center in New York City, and colleagues retrospectively reviewed the outcomes of 181 patients with who received in the ICU at a single center versus a matched cohort of ICU patients who did not receive chemotherapy.

The researchers found that the ICU and hospital mortality rates were 25 and 42 percent, respectively, for , compared to 22 and 33 percent, respectively, for non-chemotherapy patients. Patients who did receive chemotherapy had a significantly longer length of stay in the ICU (median, six versus three days; P < 0.001) and in the hospital (median, 22 versus 14 days; P = 0.024), compared with patients not receiving chemotherapy. There was a trend toward a higher risk of dying by 12 months among patients receiving chemotherapy in the ICU versus those who did not (hazard ratio, 1.45; P < 0.08).

"Short‐term mortality was similar among patients with hematologic malignancies who did and did not receive chemotherapy in the ICU, although patients who received chemotherapy had increased resource utilization," the authors write. "These results may inform ICU triage and goals-of-care discussions with patients and their families regarding outcomes after receiving chemotherapy in the ICU."

Explore further: Private insurance coverage of infused chemo varies by setting

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Private insurance coverage of infused chemo varies by setting

February 23, 2018
(HealthDay)—From 2004 to 2014, there was an increase in the provision of infused chemotherapy in hospital outpatient departments (HOPDs), which is associated with increased spending, according to a research letter published ...

Small-cell lung cancer patients face barriers to receiving standard-of-care treatment

January 4, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients ...

Optimal timing ID'd for flu shot during three-week chemo cycle

December 28, 2016
(HealthDay)—For adults with solid cancer undergoing three-week cytotoxic chemotherapy cycles, antibody responses are comparable for influenza vaccination on day one and 11, according to a study published online Dec. 20 ...

Cystectomy plus chemo ups survival in bladder cancer

January 21, 2016
(HealthDay)—For patients with locally advanced bladder cancer, cystectomy plus adjuvant chemotherapy is associated with improved survival versus cystectomy alone, according to a study published online Jan. 19 in the Journal ...

Disparities seen in gastric cancer patients' receipt of pre-op chemo

February 13, 2018
(HealthDay)—Racial and ethnic disparities in the use of preoperative chemotherapy exist among patients with gastric cancer in the United States, according to a study published online Feb. 2 in Cancer.

70-gene signature impacts treatment decisions in breast CA

October 29, 2017
(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a study published online ...

Recommended for you

Research team discovers drug compound that stops cancer cells from spreading

June 22, 2018
Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body. New research, published today in the journal Nature ...

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.